Schedule 13D ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q101

Event date: 2014-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,859,639
Percent of class
13.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-047631
Form type
SC 13D
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Aug 07, 2014
Reporting period
Jul 31, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub